Company Filing History:
Years Active: 2023
Title: The Innovative Contributions of Shu-Ying Wang
Introduction: Shu-Ying Wang is a prominent inventor based in Tainan, Taiwan. He has made significant strides in the field of vaccine development, particularly focusing on dengue fever. His work is characterized by a commitment to enhancing public health through innovative solutions.
Latest Patents: One of Shu-Ying Wang's notable patents is the "Composition of subunit dengue vaccine." This invention relates to a composition that includes a fusion protein of conjugating or connecting delta C nonstructural protein 1 (NS1) to at least one polypeptide of NS3c and/or consensus envelope protein domain III (cEDIII). This innovative approach aims to provide better protection against dengue virus (DENV) challenges while alleviating associated pathological effects. He holds 1 patent in this area.
Career Highlights: Shu-Ying Wang is affiliated with National Cheng Kung University, where he contributes to research and development in the field of immunology and vaccine technology. His academic background and research endeavors have positioned him as a key figure in the fight against infectious diseases.
Collaborations: Throughout his career, Shu-Ying Wang has collaborated with esteemed colleagues, including Yee-Shin Lin and Trai-Ming Yeh. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.
Conclusion: Shu-Ying Wang's contributions to vaccine development, particularly in the area of dengue fever, highlight his innovative spirit and dedication to improving global health. His work continues to inspire future advancements in immunology and public health.